ANCA-Associated Vasculitis

Pathogenesis, Models, and Preclinical Testing

Research output: Contribution to journalReview ArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Summary: Our understanding of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has developed greatly since the discovery of ANCA, directed against neutrophil components, in 1982. Observations in human disease, and increasingly sophisticated studies in vitro and in rodent models in vivo, have allowed a nuanced understanding of many aspects of the immunopathogenesis of disease, including the significance of ANCA as a diagnostic and monitoring tool as well as a mediator of microvascular injury. The mechanisms of leukocyte recruitment and tissue injury, and the role of T cells increasingly are understood. Unexpected findings, such as the role of complement, also have been uncovered through experimental studies and human observations. This review focusses on the pathogenesis of ANCA-associated vasculitis, highlighting the challenges in finding new, less-toxic treatments and potential therapeutic targets in this disease. The current suite of rodent models is reviewed, and future directions in the study of this complex and fascinating disease are suggested.

Original languageEnglish
Pages (from-to)418-435
Number of pages18
JournalSeminars in Nephrology
Volume37
Issue number5
DOIs
Publication statusPublished - 1 Sep 2017

Keywords

  • ANCA
  • glomerulonephritis
  • immunology
  • vasculitis

Cite this

@article{d82c2629ea464384bb0dbcda4cb777b4,
title = "ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing",
abstract = "Summary: Our understanding of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has developed greatly since the discovery of ANCA, directed against neutrophil components, in 1982. Observations in human disease, and increasingly sophisticated studies in vitro and in rodent models in vivo, have allowed a nuanced understanding of many aspects of the immunopathogenesis of disease, including the significance of ANCA as a diagnostic and monitoring tool as well as a mediator of microvascular injury. The mechanisms of leukocyte recruitment and tissue injury, and the role of T cells increasingly are understood. Unexpected findings, such as the role of complement, also have been uncovered through experimental studies and human observations. This review focusses on the pathogenesis of ANCA-associated vasculitis, highlighting the challenges in finding new, less-toxic treatments and potential therapeutic targets in this disease. The current suite of rodent models is reviewed, and future directions in the study of this complex and fascinating disease are suggested.",
keywords = "ANCA, glomerulonephritis, immunology, vasculitis",
author = "Hutton, {Holly L.} and Holdsworth, {Stephen R.} and Kitching, {A. Richard}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.semnephrol.2017.05.016",
language = "English",
volume = "37",
pages = "418--435",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "Elsevier",
number = "5",

}

ANCA-Associated Vasculitis : Pathogenesis, Models, and Preclinical Testing. / Hutton, Holly L.; Holdsworth, Stephen R.; Kitching, A. Richard.

In: Seminars in Nephrology, Vol. 37, No. 5, 01.09.2017, p. 418-435.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - ANCA-Associated Vasculitis

T2 - Pathogenesis, Models, and Preclinical Testing

AU - Hutton, Holly L.

AU - Holdsworth, Stephen R.

AU - Kitching, A. Richard

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Summary: Our understanding of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has developed greatly since the discovery of ANCA, directed against neutrophil components, in 1982. Observations in human disease, and increasingly sophisticated studies in vitro and in rodent models in vivo, have allowed a nuanced understanding of many aspects of the immunopathogenesis of disease, including the significance of ANCA as a diagnostic and monitoring tool as well as a mediator of microvascular injury. The mechanisms of leukocyte recruitment and tissue injury, and the role of T cells increasingly are understood. Unexpected findings, such as the role of complement, also have been uncovered through experimental studies and human observations. This review focusses on the pathogenesis of ANCA-associated vasculitis, highlighting the challenges in finding new, less-toxic treatments and potential therapeutic targets in this disease. The current suite of rodent models is reviewed, and future directions in the study of this complex and fascinating disease are suggested.

AB - Summary: Our understanding of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has developed greatly since the discovery of ANCA, directed against neutrophil components, in 1982. Observations in human disease, and increasingly sophisticated studies in vitro and in rodent models in vivo, have allowed a nuanced understanding of many aspects of the immunopathogenesis of disease, including the significance of ANCA as a diagnostic and monitoring tool as well as a mediator of microvascular injury. The mechanisms of leukocyte recruitment and tissue injury, and the role of T cells increasingly are understood. Unexpected findings, such as the role of complement, also have been uncovered through experimental studies and human observations. This review focusses on the pathogenesis of ANCA-associated vasculitis, highlighting the challenges in finding new, less-toxic treatments and potential therapeutic targets in this disease. The current suite of rodent models is reviewed, and future directions in the study of this complex and fascinating disease are suggested.

KW - ANCA

KW - glomerulonephritis

KW - immunology

KW - vasculitis

UR - http://www.scopus.com/inward/record.url?scp=85021373767&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2017.05.016

DO - 10.1016/j.semnephrol.2017.05.016

M3 - Review Article

VL - 37

SP - 418

EP - 435

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 5

ER -